Aurobindo Pharma on Monday said its consolidated net profit increased 8 per cent year-on-year to Rs 910 crore for the December quarter, led by robust sales in Europe and the US.
The Hyderabad-based drug major reported a net profit of Rs 846 crore for the October-December period of the last fiscal year.
Total revenue from operations increased to Rs 8,646 crore during the quarter as compared with Rs 7,979 crore in the year-ago period, the drug firm said in a statement.
"Q3 reflected steady execution across Aurobindo's core businesses... Читать дальше...